Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells

Oral squamous cell carcinoma (OSCC), an aggressive and poorly prognosed subtype of head and neck squamous cell carcinoma (HNSCC), has prompted urgent calls for innovative therapeutic approaches. Evodiamine (EVO), a natural alkaloid extracted from the Chinese herb <i>Evodia rutaecarpa</i>...

Full description

Saved in:
Bibliographic Details
Main Authors: Gang Chen, Hong-Liang Du, Jia-Nan Liu, Jie Cheng, Jing Chen, Xiao-Yang Yin, Hu-Lai Wei, Jing Wang
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/47/7/558
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839616276863909888
author Gang Chen
Hong-Liang Du
Jia-Nan Liu
Jie Cheng
Jing Chen
Xiao-Yang Yin
Hu-Lai Wei
Jing Wang
author_facet Gang Chen
Hong-Liang Du
Jia-Nan Liu
Jie Cheng
Jing Chen
Xiao-Yang Yin
Hu-Lai Wei
Jing Wang
author_sort Gang Chen
collection DOAJ
description Oral squamous cell carcinoma (OSCC), an aggressive and poorly prognosed subtype of head and neck squamous cell carcinoma (HNSCC), has prompted urgent calls for innovative therapeutic approaches. Evodiamine (EVO), a natural alkaloid extracted from the Chinese herb <i>Evodia rutaecarpa</i>, has demonstrated significant potential in curbing tumor cell proliferation and slowing tumor expansion. However, its specific effects on cell senescence within the context of OSCC have remained shrouded in uncertainty. This study delves into the mechanisms of EVO’s impact on OSCC by harnessing databases such as the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and CellAge to pinpoint potential targets and carry out in-depth bioinformatics analysis. The findings reveal that EVO can markedly enhance the expression of the androgen receptor (AR) in OSCC cells, inducing cellular senescence and thereby inhibiting tumor progression. Furthermore, the research indicates that AR expression is considerably lower in OSCC tissues than in normal tissues. This low expression of AR in tumor tissues is closely associated with advanced clinical stages and unfavorable prognoses in HNSCC patients. These discoveries open up new avenues for therapeutic strategies, and suggest that AR holds promise as a potential therapeutic target for OSCC, and EVO may amplify its antitumor effects by enhancing AR-mediated cellular senescence in the treatment of OSCC.
format Article
id doaj-art-d6924f83c42b4394975c1102df9bce31
institution Matheson Library
issn 1467-3037
1467-3045
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-d6924f83c42b4394975c1102df9bce312025-07-25T13:18:47ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452025-07-0147755810.3390/cimb47070558Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC CellsGang Chen0Hong-Liang Du1Jia-Nan Liu2Jie Cheng3Jing Chen4Xiao-Yang Yin5Hu-Lai Wei6Jing Wang7School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, ChinaThe First Hospital of Lanzhou University, Lanzhou 730000, ChinaGeneral Practitioner Primary Training Base of the First Hospital of Lanzhou University, Lanzhou 730000, ChinaSchool of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, ChinaSchool of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, ChinaSchool of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, ChinaSchool of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, ChinaHospital of Stomatology, Lanzhou University, Lanzhou 730000, ChinaOral squamous cell carcinoma (OSCC), an aggressive and poorly prognosed subtype of head and neck squamous cell carcinoma (HNSCC), has prompted urgent calls for innovative therapeutic approaches. Evodiamine (EVO), a natural alkaloid extracted from the Chinese herb <i>Evodia rutaecarpa</i>, has demonstrated significant potential in curbing tumor cell proliferation and slowing tumor expansion. However, its specific effects on cell senescence within the context of OSCC have remained shrouded in uncertainty. This study delves into the mechanisms of EVO’s impact on OSCC by harnessing databases such as the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and CellAge to pinpoint potential targets and carry out in-depth bioinformatics analysis. The findings reveal that EVO can markedly enhance the expression of the androgen receptor (AR) in OSCC cells, inducing cellular senescence and thereby inhibiting tumor progression. Furthermore, the research indicates that AR expression is considerably lower in OSCC tissues than in normal tissues. This low expression of AR in tumor tissues is closely associated with advanced clinical stages and unfavorable prognoses in HNSCC patients. These discoveries open up new avenues for therapeutic strategies, and suggest that AR holds promise as a potential therapeutic target for OSCC, and EVO may amplify its antitumor effects by enhancing AR-mediated cellular senescence in the treatment of OSCC.https://www.mdpi.com/1467-3045/47/7/558evodiamineandrogen receptororal squamous cell carcinomasenescence
spellingShingle Gang Chen
Hong-Liang Du
Jia-Nan Liu
Jie Cheng
Jing Chen
Xiao-Yang Yin
Hu-Lai Wei
Jing Wang
Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
Current Issues in Molecular Biology
evodiamine
androgen receptor
oral squamous cell carcinoma
senescence
title Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
title_full Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
title_fullStr Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
title_full_unstemmed Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
title_short Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
title_sort evodiamine boosts ar expression to trigger senescence and halt proliferation in oscc cells
topic evodiamine
androgen receptor
oral squamous cell carcinoma
senescence
url https://www.mdpi.com/1467-3045/47/7/558
work_keys_str_mv AT gangchen evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells
AT hongliangdu evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells
AT jiananliu evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells
AT jiecheng evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells
AT jingchen evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells
AT xiaoyangyin evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells
AT hulaiwei evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells
AT jingwang evodiamineboostsarexpressiontotriggersenescenceandhaltproliferationinoscccells